Three articles regarding the effects of (gene-modified) bone marrow mesenchymal stem cells transplantation for treatment of spinal cord injury and the migration process and distribution of transplanted stem cells observed by *in vivo* magnetic resonance imaging tracking, providing experimental evidence for spinal cord injury treatment with stem cell transplantation were reported in *Neural Regeneration Research*. We hope that our readers find these papers useful to their research.

**Abstract**

Bone marrow mesenchymal stem cells were isolated, purified and cultured *in vitro* by Percoll density gradient centrifugation combined with the cell adherence method. Passages 3--5 bone marrow mesenchymal stem cells were transplanted into rats with traumatic spinal cord injury *via* the caudal vein. Basso-Beattie-Bresnahan scores indicate that neurological function of experimental rats was significantly improved over transplantation time (1--5 weeks). Expressions of choline acetyltransferase, glutamic acid decarboxylase and synapsins in the damaged spinal cord of rats were significantly increased after transplantation, determined by immunofluorescence staining and laser confocal scanning microscopy. Bone marrow mesenchymal stem cells that had migrated into the damaged area of rats in the experimental group began to express choline acetyltransferase, glutamic acid decarboxylase and synapsins, 3 weeks after transplantation. The Basso-Beattie- Bresnahan scores positively correlated with expression of choline acetyltransferase and synapsins. Experimental findings indicate that intravenously transplanted bone marrow mesenchymal stem cells traverse into the damaged spinal cord of rats, promote expression of choline acetyltransferase, glutamic acid decarboxylase and synapsins, and improve nerve function in rats with spinal cord injury.
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**Abstract**

Rat bone marrow mesenchymal stem cells expressing brain-derived neurotrophic factor were successfully obtained using a gene transfection method, then intravenously transplanted into rats with spinal cord injury. At 1, 3, and 5 weeks after transplantation, the expression of brain-derived neurotrophic factor and neurofilament-200 was upregulated in the injured spinal cord, spinal cord injury was alleviated, and Basso-Beattie-Bresnahan scores of hindlimb motor function were significantly increased. This evidence suggested that intravenous transplantation of adenovirus- mediated brain-derived neurotrophic factor gene-modified rat bone marrow mesenchymal stem cells could play a dual role, simultaneously providing neural stem cells and neurotrophic factors.
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**Abstract**

Non-invasive tracing *in vivo* can be used to observe the migration and distribution of grafted stem cells, and can provide experimental evidence for treatment. This study utilized adenovirus-carrying enhanced green fluorescent protein (AD5/F35-eGFP) and superparamagnetic iron oxide (SPIO)-labeled bone marrow mesenchymal stem cells (BMSCs). BMSCs, double-labeled by AD5/F35-eGFP and SPIO, were transplanted into rats with spinal cord injury *via* the subarachnoid space. MRI tracing results demonstrated that BMSCs migrated to the injured spinal cord over time (T2 hypointensity signals). This result was verified by immunofluorescence. These results indicate that MRI can be utilized to trace *in vivo* the SPIO-labeled BMSCs after grafting.
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